Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'
- PMID: 25756506
- PMCID: PMC4622992
- DOI: 10.1080/15384047.2014.1002368
Are there alternative ways to quantify the real benefit of novel agents in oncology? - the 'death pace'
Figures
Comment on
-
Improved survival with bevacizumab in advanced cervical cancer.N Engl J Med. 2014 Feb 20;370(8):734-43. doi: 10.1056/NEJMoa1309748. N Engl J Med. 2014. PMID: 24552320 Free PMC article. Clinical Trial.
References
-
- Goey AK, Figg WD. Potential novel role of bevacizumab in glioblastoma and cervical cancer. Cancer Biol Ther 2014. Oct; 15(10):1296-8; Epub 2014 Jul 21; PMID:25046485; http://dx.doi.org/ 10.4161/cbt.29926 - DOI - PMC - PubMed
-
- Tewari KS, Sill MW, Long HJ, 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 2014; 370:734-43; PMID:24552320; http://dx.doi.org/ 10.1056/NEJMoa1309748 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical